Wednesday, August 26, 2020

NasdaqAdma Top Important Factors To Consider

Introduction about NASDAQ: ADMA

ADMA Biologics, Inc. is a biopharmaceutical company that mainly deals with the marketing, manufacturing, and development of some plasma-derived biologics. The company was mainly founded by Adam S. Grossman and Jerrold B. Grossman. This company is headquartered in Hackensack, NJ. This company is registered under Nasdaq with the name “adma”. Some information about NASDAQ: ADMA at

Top reasons to invest in the pharmaceutical industry:

  1. The pharmaceuticals sector has been the source of strong growth, in spite of having the potentially high-risk category of the business. This industry is mainly dependent on the research and development of some new products, and patent protection. The industry has mainly experienced about 3 percent annual growth rate since 2014. Some of the agencies are mainly projecting the growth of 2 percent to 5 percent to exceed the revenue of $1.1 trillion in 2024.
  2. Today, the biopharmaceutical company normally generates global revenues of $163 billion, which makes up about 20 percent of the pharma market. This is the fastest-growing area of the pharma industry. The biopharma company’s current annual growth rate is more than 8 percent which is double the amount of the conventional pharma, and the growth rate is expected to rise.
  3. The efficacy and safety of biopharmaceutical products, which is mainly combined with their ability to address some of the previously untreatable conditions.  The pharmaceutical companies mainly develop products according to people's needs. These companies produce some of the drugs which treat or prevent diseases and the vaccines for immunization against bacterial and viral infections. They continuously invest in the research and development to launch some new drugs. The increase in the number of older people, many of whom need prescription medicines, is an advantage to the healthcare sector, particularly the pharma companies.
  4. There is a very good scope for the long-term earnings. One can just sell the same drugs in different markets. There is a lot of scope for the mergers and acquisitions in the pharmaceutical sector.

Some of the top facts to know about ADMA Biologics, Inc

This company was founded in the year 2004. As far as the revenue growth is concerned, the ADMA's revenue has grown by 102.69% over the past 12 months. This company has got a nice shareholders yield. Shareholder’s yield means how much capital has been returned to the stockholders through the dividends. Some of the similar stocks like ADMA are TTMI, MNKD, and SWM.

One should study about the financial portfolio of the company before investing. These biopharma companies are the key pillars of many countries' economies. You can find stocks to invest in after checking more stock news.

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Author: verified_user